FDA Approvals

Date Posted
Article Title
4/2/2014
Under-the-Tongue Tablet Approved for Grass Allergies

To be started 4 months before allergy season

3/31/2014
Long-Acting Clotting Agent Approved for Form of Hemophilia

Alprolix requires less frequent injections

3/31/2014
Topamax Approval for Migraines Expanded to Younger Users

Adolescents ages 12-17 can now take the drug, FDA says

3/21/2014
Otezla Approved for Psoriatic Arthritis

Condition affects some with psoriasis

3/20/2014
Implanted Hearing Device Approved

For common type of hearing loss

3/20/2014
Impavido Approved to Treat Tropical Parasitic Disease

Americans typically contract it while traveling

3/12/2014
First Device Approved to Prevent Migraines

Headband-like unit stimulates nerve associated with painful headaches

2/25/2014
Myalept Approved for Rare Fat Tissue Disorder

Drug is meant for people with deficiency of the hormone leptin

2/19/2014
Northera Approved For Rare Blood Pressure Condition

Neurogenic orthostatic hypotension is most often tied to Parkinson's disease

2/17/2014
2/12/2014
Imbruvica Approval Expanded to Include Chronic Leukemia

Drug inhibits enzyme that spurs cancer growth

2/4/2014
Blood Sugar Monitoring System Approved for Children

However, device didn't perform as well in kids as in adults, FDA says

1/31/2014
Hetlioz Approved for Sleep Disorder in Blind People

Condition stems from inability to govern sleep from light-dark cycle

1/17/2014
New Test Helps Diagnose Intellectual Disability in Children

Scan tracks entire genome from a blood sample

1/10/2014
Mekinist Plus Tafinlar Approved for Late-Stage Melanoma

The most deadly form of skin cancer

1/10/2014
Sealant Gel Approved for Eye Surgery

An additional option after cataract operation

1/8/2014
Farxiga Approved for Type 2 Diabetes

Along with diet and exercise

12/23/2013
Tretten Approved for Genetic Clotting Disorder

Rare condition could be life threatening

12/19/2013
Stent to Treat Pancreatic Cysts Approved

For infected cysts that won't drain on their own

12/18/2013
Anoro Ellipta Approved for COPD

Drug relaxes lung airways